Skip to main content

Table 5 Five- and 10-year observed and relative survival of GIST

From: Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study

Type of mutation

Time (years)

N at risk

OS (95% confidence interval)

RS (95% confidence interval)

c-KIT exon 11

5

35

59.6 (48.2 to 73.8)

66.3 (53.6 to 82.1)

 

10

15

50.6 (38.5 to 66.5)

65.7 (50.0 to 82.1)

c-KIT exon 9

5

8

87.5 (67.3 to 100.0)

87.5 (67.3 to 100.0)

 

10

4

60.0 (33.1 to 100.0)

65.3 (36.1 to 108.8)

PDGFR-α exon 18

5

12

84.6 (67.1 to 100.0)

89.7 (71.1 to 106.0)

 

10

7

84.6 (67.1 to 100.0)

108.8 (86.3 to 128.6)

Wild type

5

22

75.0 (60.6 to 92.9)

83.6 (67.5 to 103.5)

 

10

14

67.0 (51.3 to 87.4)

79.9 (61.3 to 104.3)

  1. According to type of c-KIT or PDGFR-α gene mutation (N = 108).